LATEST NEWS

ProMISTM Neurosciences, Inc. new strategic direction

View Investment Summary
We have now successfully completed the strategic assessment of the Company ...


Letter from the Chairman

View letter

LATEST PRESS RELEASE

Amorfix Life Sciences, Ltd. Announces Results of Annual and Special Meeting of Shareholders

June 30, 2015

View

View pass press releases

TSX:AMF listed

Amorfix Life Sciences Ltd. (TSX:AMF) is a theranostics company developing therapeutic products and diagnostic devices targeting misfolded protein diseases including ALS, cancer, and Alzheimer's Disease.

Amorfix is a pioneer in the ability to identify unique regions that are buried in normal proteins, and exposed to antibodies when proteins are aberrantly folded. These unique regions are designated Disease Specific Epitopes™ (DSE), which can be exploited by Amorfix to develop highly specific diagnostic tools, as well as targets for therapeutics of protein misfolding diseases.

amorfix life sciences